Lymph node trafficking of regulatory T cells is prerequisite for immune suppression

Journal of Leukocyte Biology

Volumn 99, Issue 4, 2016, Pages 561-568

  Huang, Miao Tzu ^a   Lin, Been Ren ^a   Liu, Wei Liang ^a   Lu, Chun Wei ^a   Chiang, Bor Luen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

CCR7; Footpad inflammation; Immune regulation; Leukocyte trafficking

Indexed keywords

BLOCKING ANTIBODY; CHEMOKINE RECEPTOR CCR7; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; CCR7 PROTEIN, MOUSE; NEUTRALIZING ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; EFFECTOR CELL; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFLAMMATION; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SHEAR FLOW; SHEAR STRESS; SURFACE PROPERTY; T LYMPHOCYTE ACTIVATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL MOTION; DRUG EFFECTS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PATHOLOGY; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, NEUTRALIZING; CELL MOVEMENT; IMMUNE TOLERANCE; INFLAMMATION; L-SELECTIN; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; RECEPTORS, CCR7; T-LYMPHOCYTES, REGULATORY;

EID: 84962467964     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1A0715-296R     Document Type: Article

References (38)

1. Faria, A. M., Weiner, H. L. (2005) Oral tolerance. Immunol. Rev. 206, 232–259.
2. Nagler-Anderson, C., Strober, W. (2004) Mechanisms of oral tolerance: regulatory T cells—summary of part III. Ann. N. Y. Acad. Sci. 1029, 169–171.
3. Mayer, L., Shao, L. (2004) Therapeutic potential of oral tolerance. Nat. Rev. Immunol. 4, 407–419.
4. Strober, W. (2004) Oral tolerance: animal disease models and human trials—summary of part V. Ann. N. Y. Acad. Sci. 1029, 310–312.
5. Wardrop, R. M., III, Whitacre, C. C. (1999) Oral tolerance in the treatment of inflammatory autoimmune diseases. Inflamm. Res. 48, 106–119.
6. Akbari, O., Stock, P., DeKruyff, R. H., Umetsu, D. T. (2003) Role of regulatory T cells in allergy and asthma. Curr. Opin. Immunol. 15, 627–633.
7. Robinson, D. S., Larché, M., Durham, S. R. (2004) Tregs and allergic disease. J. Clin. Invest. 114, 1389–1397.
8. Lu, L. F., Rudensky, A. (2009) Molecular orchestration of differentiation and function of regulatory T cells. Genes Dev. 23, 1270–1282.
9. Sakaguchi, S. (2008) Regulatory T cells in the past and for the future. Eur. J. Immunol. 38, 901–937.
10. Chapoval, S., Dasgupta, P., Dorsey, N. J. and Keegan, A. D. (2010) Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6. J. Leukoc. Biol. 87, 1011–1018.
11. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J. F., Enjyoji, K., Linden, J., Oukka, M., Kuchroo, V. K., Strom, T. B., Robson, S. C. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257–1265.
12. Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., Höpner, S., Centonze, D., Bernardi, G., Dell’Acqua, M. L., Rossini, P. M., Battistini, L., Rötzschke, O., Falk, K. (2007) Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110, 1225–1232.
13. Kobie, J. J., Shah, P. R., Yang, L., Rebhahn, J. A., Fowell, D. J., Mosmann, T. R. (2006) T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 59-adenosine monophosphate to adenosine. J. Immunol. 177, 6780–6786.
14. Lu, L. F., Boldin, M. P., Chaudhry, A., Lin, L. L., Taganov, K. D., Hanada, T., Yoshimura, A., Baltimore, D., Rudensky, A. Y. (2010) Function of miR- 146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142, 914–929.
15. Jalkanen, S., Reichert, R. A., Gallatin, W. M., Bargatze, R. F., Weissman, I. L., Butcher, E. C. (1986) Homing receptors and the control of lymphocyte migration. Immunol. Rev. 91, 39–60.
16. Nourshargh, S., Marelli-Berg, F. M. (2005) Transmigration through venular walls: a key regulator of leukocyte phenotype and function. Trends Immunol. 26, 157–165.
17. Mirenda, V., Millington, O., Lechler, R. I., Scott, D., Hernandez-Fuentes, M. P., Read, J., Tan, P. H., George, A. J., Garside, P., Marelli-Berg, F. M. (2005) Tolerant T cells display impaired trafficking ability. Eur. J. Immunol. 35, 2146–2156.
18. Marelli-Berg, F. M., Frasca, L., Weng, L., Lombardi, G., Lechler, R. I. (1999) Antigen recognition influences transendothelial migration of CD4+ T cells. J. Immunol. 162, 696–703.
19. James, M. J., Belaramani, L., Prodromidou, K., Datta, A., Nourshargh, S., Lombardi, G., Dyson, J., Scott, D., Simpson, E., Cardozo, L., Warrens, A., Szydlo, R. M., Lechler, R. I., Marelli-Berg, F. M. (2003) Anergic T cells exert antigen-independent inhibition of cell–cell interactions via chemokine metabolism. Blood 102, 2173–2179.
20. Ochando, J. C., Yopp, A. C., Yang, Y., Garin, A., Li, Y., Boros, P., Llodra, J., Ding, Y., Lira, S. A., Krieger, N. R., Bromberg, J. S. (2005) Lymph node occupancy is required for the peripheral development of alloantigenspecific Foxp3+ regulatory T cells. J. Immunol. 174, 6993–7005.
21. Siegmund, K., Feuerer, M., Siewert, C., Ghani, S., Haubold, U., Dankof, A., Krenn, V., Schön, M. P., Scheffold, A., Lowe, J. B., Hamann, A., Syrbe, U., Huehn, J. (2005) Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106, 3097–3104.
22. Denning, T. L., Kim, G., Kronenberg, M. (2005) Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis. J. Immunol. 174, 7487–7491.
23. Zhang, N., Schröppel, B., Lal, G., Jakubzick, C., Mao, X., Chen, D., Yin, N., Jessberger, R., Ochando, J. C., Ding, Y., Bromberg, J. S. (2009) Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 30, 458–469.
24. Zhang, X., Izikson, L., Liu, L., Weiner, H. L. (2001) Activation of CD25+CD4+ regulatory T cells by oral antigen administration. J. Immunol. 167, 4245–4253.
25. Huang, M. T., Mason, J. C., Birdsey, G. M., Amsellem, V., Gerwin, N., Haskard, D. O., Ridley, A. J., Randi, A. M. (2005) Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis. Blood 106, 1636–1643.
26. Huang, M. T., Dai, Y. S., Chou, Y. B., Juan, Y. H., Wang, C. C., Chiang, B. L. (2009) Regulatory T cells negatively regulate neovasculature of airway remodeling via DLL4-Notch signaling. J. Immunol. 183, 4745–4754.
27. Schneider, M. A., Meingassner, J. G., Lipp, M., Moore, H. D., Rot, A. (2007) CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J. Exp. Med. 204, 735–745.
28. Fu, S., Yopp, A. C., Mao, X., Chen, D., Zhang, N., Chen, D., Mao, M., Ding, Y., Bromberg, J. S. (2004) CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential. Am. J. Transplant. 4, 65–78.
29. Szanya, V., Ermann, J., Taylor, C., Holness, C., Fathman, C. G. (2002) The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169, 2461–2465.
30. Agenès, F., Bosco, N., Mascarell, L., Fritah, S., Ceredig, R. (2005) Differential expression of regulator of G-protein signalling transcripts and in vivo migration of CD4+ naïve and regulatory T cells. Immunology 115, 179–188.
31. Gavin, M. A., Clarke, S. R., Negrou, E., Gallegos, A., Rudensky, A. (2002) Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat. Immunol. 3, 33–41.
32. Abeynaike, L. D., Deane, J. A., Westhorpe, C. L. V., Chow, Z., Alikhan, M. A., Kitching, A. R., Issekutz, A., Hickey, M. J. (2014) Regulatory T cells dynamically regulate selectin ligand function during multiple challenge contact hypersensitivity. J. Immunol. 193, 4934–4944.
33. Davalos-Misslitz, A. C., Rieckenberg, J., Willenzon, S., Worbs, T., Kremmer, E., Bernhardt, G., Förster, R. (2007) Generalized multi-organ autoimmunity in CCR7-deficient mice. Eur. J. Immunol. 37, 613–622.
34. Lathrop, S. K., Santacruz, N. A., Pham, D., Luo, J., Hsieh, C. S. (2008) Antigen-specific peripheral shaping of the natural regulatory T cell population. J. Exp. Med. 205, 3105–3117.
35. Samy, E. T., Parker, L. A., Sharp, C. P., Tung, K. S. K. (2005) Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node. J. Exp. Med. 202, 771–781.
36. Wheeler, K. M., Samy, E. T., Tung, K. S. K. (2009) Cutting edge: normal regional lymph node enrichment of antigen-specific regulatory T cells with autoimmune disease-suppressive capacity. J. Immunol. 183, 7635–7638.
37. Huehn, J., Hamann, A. (2005) Homing to suppress: address codes for Treg migration. Trends Immunol. 26, 632–636.
38. Mottet, C., Uhlig, H. H., Powrie, F. (2003) Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol. 170, 3939–3943.